US Patent 11834661 Angiotensinogen (AGT) iRNA compositions and methods of use thereof
Patent 11834661 was granted and assigned to Alnylam Pharmaceuticals on December, 2023 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11834661 Angiotensinogen (AGT) iRNA compositions and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
